Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C71H110N28O13 |
Molecular Weight | 1563.8129 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 11 / 11 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@@H](N)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@H](CC1=CN=CN1)C(=O)N[C@H](CC2=CN=CN2)C(=O)NCC(=O)N[C@H](CC3=CC=C(O)C=C3)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC4=CC=CC=C4)C(=O)N[C@H](CC5=CN=CN5)C(N)=O
InChI
InChIKey=UIBPZXXSPHGPDS-UXLZJAPBSA-N
InChI=1S/C71H110N28O13/c1-41(75)60(103)91-48(15-5-8-24-72)62(105)94-52(19-12-28-85-71(79)80)66(109)99-57(33-46-36-83-40-89-46)69(112)98-56(32-45-35-82-39-88-45)61(104)86-37-58(101)90-54(30-43-20-22-47(100)23-21-43)67(110)95-49(16-6-9-25-73)63(106)93-51(18-11-27-84-70(77)78)64(107)92-50(17-7-10-26-74)65(108)97-55(29-42-13-3-2-4-14-42)68(111)96-53(59(76)102)31-44-34-81-38-87-44/h2-4,13-14,20-23,34-36,38-41,48-57,100H,5-12,15-19,24-33,37,72-75H2,1H3,(H2,76,102)(H,81,87)(H,82,88)(H,83,89)(H,86,104)(H,90,101)(H,91,103)(H,92,107)(H,93,106)(H,94,105)(H,95,110)(H,96,111)(H,97,108)(H,98,112)(H,99,109)(H4,77,78,84)(H4,79,80,85)/t41-,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-/m1/s1
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
156502
Created by
admin on Fri Dec 15 15:17:29 UTC 2023 , Edited by admin on Fri Dec 15 15:17:29 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
513P3772TA
Created by
admin on Fri Dec 15 15:17:29 UTC 2023 , Edited by admin on Fri Dec 15 15:17:29 UTC 2023
|
PRIMARY | |||
|
16158147
Created by
admin on Fri Dec 15 15:17:29 UTC 2023 , Edited by admin on Fri Dec 15 15:17:29 UTC 2023
|
PRIMARY | |||
|
DTXSID90172563
Created by
admin on Fri Dec 15 15:17:29 UTC 2023 , Edited by admin on Fri Dec 15 15:17:29 UTC 2023
|
PRIMARY | |||
|
190673-60-0
Created by
admin on Fri Dec 15 15:17:29 UTC 2023 , Edited by admin on Fri Dec 15 15:17:29 UTC 2023
|
PRIMARY |
ACTIVE MOIETY